Fingerprint
Dive into the research topics where Sarah Tasian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 3 Article
-
Clinical activity of venetoclax and azacitidine in children with de novo or secondary multiple relapsed/refractory acute myeloid leukemia: A real-world experience
Arcourt, A., Ilan, U., Murillo, L., Arad-Cohen, N., Rubio, A., Tasian, S. K., Baruchel, A., Zwaan, C. M., Ducassou, S. & Goemans, B. F., 16 Oct 2025, In: Haematologica. 111, 3, p. 852-860 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents
Tasian, S. K., Boer, J. M. & den Boer, M. L., Dec 2025, In: EJC Paediatric Oncology. 6, 100304.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain
van Outersterp, I., Tasian, S. K., Reichert, C. E. J., Boeree, A., de Groot-Kruseman, H. A., Escherich, G., Boer, J. M. & den Boer, M. L., 23 May 2024, In: Blood. 143, 21, p. 2178-2189 12 p.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus)